Absrtact: Medical software company Lumiata received 6 million dollars a round of financing, so far it has received a total of 10 million dollars in investment. Lumiata is the first company to propose a medical atlas (Jude Graph) that integrates electronic medical records with pathophysiological data and
Lumiata, a healthcare software company, has received $6 million trillion in a round of funding, which has now received a total of 10 million dollars in investment.
Lumiata, the first company to put forward the "Medical Atlas", integrates data such as electronic medical records and pathophysiology, and simulates the human multidimensional reasoning process in the form of Atlas analysis, which predicts what the patient needs and when it needs it. Using this data, Lumiata can also analyze and predict the overall health of a population.
By transforming the data into maps, Lumiata can classify patients more effectively and obtain more accurate prescription information, which is mainly about symptoms, drugs, risk factors for illness, and doctor's diagnosis. Using this atlas, doctors can make more rapid and targeted diagnoses of patients. Lumiata, for example, was piloted at a first-aid center with hundreds of patients, and the results showed that the time for triage was reduced by about 30% to 40%.
Lumiata sees itself as a platform to transform the world's medical knowledge and data into real-life insights into feasibility. This prediction is to answer these questions, "What to do, for who, when, why."
Today, when big data is so hot, there are few companies that can turn the data into insights, and fewer companies that can turn insights into viable practical solutions. I'm looking forward to lumiata more breakthroughs in the field of big Data medicine.